Gut Microbiota and Metabolic Syndrome: A Narrative Review.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic search or primary empirical data
PubMed 42510662 · doi:10.3390/biology15141115
What was done
Narrative review summarizing literature on the relationship between gut microbiota, diet, short-chain fatty acid production, and metabolic syndrome and its associated metabolic disorders.
What was found
The abstract contains no empirical numbers, quantitative data, or effect sizes. It describes qualitative associations linking gut dysbiosis (e.g., altered Firmicutes and Bacteroidetes abundance) to increased intestinal permeability, endotoxemia, and chronic inflammation, and notes that dietary fiber fermentation produces short-chain fatty acids (acetate, propionate, butyrate) that support metabolic and immune homeostasis.
Why it matters
Synthesizes current conceptual understanding of how gut microbiota and diet interact to influence metabolic risk, framing potential nutritional intervention targets.
Limits
As a narrative review, it lacks a systematic literature search, formal study selection criteria, and quality appraisal. No primary human data, quantitative outcomes, or specific study counts are reported in the abstract.
Cited by
- supports Colonic bacteria ferment soluble fiber into short-chain fatty acids, specifically propionate and butyrate, which exert anti-inflammatory and insulin-sensitizing effects.